Genmab News

Genmab News

In accordance with legal requirements, notifications regarding Managers’ Transactions are published in the database of the Danish Financial Supervisory Authority and can be accessed at the following link: https://oasm.dfsa.dk/uk/frontpage.aspx. As a general rule, Genmab no longer issues Company Announcements concerning these transactions.

Date Title View
May 16, 2019
Genmab Announces Data to be Presented at 24th EHA Annual Congress
190516_i07MR_EHA Curtain Raiser
May 15, 2019
Genmab A/S has published its Articles of Association
Articles of Association - May 14, 2019 (UK)
May 14, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
2019.05.14_21CA_Warrant Exercise
May 08, 2019
Genmab Announces Financial Results for the First Quarter of 2019
190508_CA20_Q1 2019 Interim Report
Apr 17, 2019
Genmab Announces Data to be Presented at 2019 ASCO Annual Meeting
i06_190417_MR_ASCO Curtain Raiser
Apr 16, 2019
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2019
190416_19_CA_Dara Q1 Sales
Apr 05, 2019
Genmab Announces Submission of Supplemental New Drug Application in Japan for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
190405_i05_MAIA Japan submission
Apr 03, 2019
Genmab A/S has published its Articles of Association
Articles of Association - April 2, 2019 (UK)
Apr 03, 2019
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
190403_CA_18_3021 Study Start
Apr 02, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
190402_CA17_Warrant Exercise
Apr 02, 2019
Genmab to Present at the H.C. Wainwright & Co. Global Life Sciences Conference
190402_i04_HCWainwright
Apr 02, 2019
Genmab A/S has published its Articles of Association
Articles of Association - March 29, 2019 (UK)
Mar 29, 2019
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
190329_CA16_Constitution of the Board and grant of RSUs and Warrants
Mar 29, 2019
Passing of Genmab A/S’ Annual General Meeting
190329_CA15_2019 AGM passing
Mar 27, 2019
Genmab Announces European Regulatory Submission for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Download PDF 36.99 KB
Mar 26, 2019
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
190322_CA13_CASSIOPEIA filing US
Mar 22, 2019
Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
190322_CA12_MAIA EU Submission
Mar 11, 2019
Genmab Announces Appointment of Marisol Peron as Head of Communications and Investor Relations
Download PDF 145.8 KB
Mar 08, 2019
Genmab A/S has published its Articles of Association
Articles of Association - March 1, 2019 (UK)
Mar 01, 2019
Grant of Restricted Stock Units and Warrants to Employees in Genmab
190301_10_CA_Warrant Grant
Feb 28, 2019
Genmab A/S Summons Annual General Meeting
190228_CA_10_AGM_Calling
Feb 27, 2019
Genmab A/S has published its Articles of Association
Articles of Association - February 26, 2019 (UK)
Feb 26, 2019
Capital Increase in Genmab as a Result of Employee Warrant Exercise
2019.02.26_09_CA_Warrant Exercise
Feb 25, 2019
Genmab Announces Positive Topline Results in Phase III COLUMBA Study of Subcutaneous Daratumumab
190225_CA_08_COLUMBA
Feb 20, 2019
Genmab 2018 Annual Report
07_Genmab_AR18_190220